Kit for detecting acute myeloid leukemia susceptibility
Patent Information
- Authority / Receiving Office
- CN Β· China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SUZHOU UNIV
- Publication Date
- 2011-08-10
- Estimated Expiration
- Not applicable Β· inactive patent
Smart Images
Figure 1
Abstract
Description
technical field
[0001] The invention relates to a kit for detecting disease susceptibility, in particular to a kit for detecting susceptibility to acute myeloid leukemia, by detecting the single nucleotide polymorphism of mitogen-activated protein kinase kinase 4 (CD44) (SNP) loci to predict susceptibility to acute myeloid leukemia. Background technique
[0002] The number of cases of hematological malignancies worldwide is about 400,000, accounting for the sixth place among all kinds of malignancies. The annual new cases in China are about 250,000, accounting for the eighth place among malignant tumors in my country. The occurrence of cancer is a multi-factor, multi-stage, multi-gene mutation process. As a key molecule of cell surface function, CD44 is involved in various important processes of tumorigenesis and development. A large number of studies have shown that the single nucleotide polymorphisms of genes related to tumor immune regulation can affect the role of the...